Evidence map›Paper›PMID 37372885›Full record

ArticleHealthcare (Basel, Switzerland)2023

A Validation Study of a Deep Learning-Based Doping Drug Text Recognition System to Ensure Safe Drug Use among Athletes.

Sang-Yong Lee, Jae-Hyeon Park, Jiwun Yoon, Ji-Yong Lee

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sang-Yong LeeCenter for Sports and Performance Analysis, Korea National Sport University, Seoul 05541, Republic of Korea.ORCID 0009-0002-8646-2208
Jae-Hyeon ParkCenter for Sports and Performance Analysis, Korea National Sport University, Seoul 05541, Republic of Korea.ORCID 0000-0002-1428-0168
Jiwun YoonCenter for Sports and Performance Analysis, Korea National Sport University, Seoul 05541, Republic of Korea.ORCID 0000-0001-8758-9249
Ji-Yong LeeCenter for Sports and Performance Analysis, Korea National Sport University, Seoul 05541, Republic of Korea.ORCID 0000-0003-4470-5339
Korea National Sport University · KR

Funding

This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea NRF- 2020S1A5A2A03044544
6 · The paper itself

Abstract

This study aimed to develop an English version of a doping drug-recognition system using deep learning-based optical character recognition (OCR) technology. A database of 336 banned substances was built based on the World Anti-Doping Agency's International Standard Prohibited List and the Korean Pharmaceutical Information Center's Drug Substance Information. For accuracy and validity analysis, 886 drug substance images, including 152 images of prescriptions and drug substance labels collected using data augmentation, were used. The developed hybrid system, based on the Tesseract OCR model, can be accessed by both a smartphone and website. A total of 5379 words were extracted, and the system showed character recognition errors regarding 91 words, showing high accuracy (98.3%). The system correctly classified all 624 images for acceptable substances, 218 images for banned substances, and incorrectly recognized 44 of the banned substances as acceptable. The validity analysis showed a high level of accuracy (0.95), sensitivity (1.00), and specificity (0.93), suggesting system validity. The system has the potential of allowing athletes who lack knowledge about doping to quickly and accurately check whether they are taking banned substances. It may also serve as an efficient option to support the development of a fair and healthy sports culture.

Indexed as

banned substancesdopingKoreaoptical character recognition

Identifiers

PMID37372885
PMCPMC10297893
OpenAlexW4380986933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.